02297.HK
Rainmed Medical Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.17
−5.17%Year over year
Reported trailing growth
- Revenue
- +0.4%
- EBITDA
- +24.4%
- EBIT
- +34.7%
- EPS
- +44.4%
- Free cash flow
- -61.3%
- Operating cash flow
- +42.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -38.8%
- EBITDA
- +29.3%
- EBIT
- +33.0%
- Net income
- +32.1%
- EPS
- +40.3%
- Free cash flow
- +42.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026